Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

Long-term plasmapheresis in conjunction with thalidomide and dexamethasone for the treatment of cutaneous ulcers and neovascular glaucoma in recalcitrant type I cryoglobulinemia.

Yang CH, Qureshi AA, Churchill WH, Saavedra AP.

JAMA Dermatol. 2014 Apr;150(4):426-8. doi: 10.1001/jamadermatol.2013.8700.

PMID:
24553496
2.

Assessment of education and computerized decision support interventions for improving transfusion practice.

Rothschild JM, McGurk S, Honour M, Lu L, McClendon AA, Srivastava P, Churchill WH, Kaufman RM, Avorn J, Cook EF, Bates DW.

Transfusion. 2007 Feb;47(2):228-39.

PMID:
17302768
3.

CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disorders.

Santos DD, Hatjiharissi E, Tournilhac O, Chemaly MZ, Leleu X, Xu L, Patterson C, Branagan AR, Manning RJ, Ho AW, Hunter ZR, Dimmock EA, Kutok JL, Churchill WH, Castells MC, Tai YT, Anderson KC, Treon SP.

Clin Lymphoma Myeloma. 2006 May;6(6):478-83.

PMID:
16796779
4.

Competency in cardiac examination skills in medical students, trainees, physicians, and faculty: a multicenter study.

Vukanovic-Criley JM, Criley S, Warde CM, Boker JR, Guevara-Matheus L, Churchill WH, Nelson WP, Criley JM.

Arch Intern Med. 2006 Mar 27;166(6):610-6. Erratum in: Arch Intern Med. 2006 Jun 26;166(12):1294.

PMID:
16567598
5.

Fulminant babesiosis treated with clindamycin, quinine, and whole-blood exchange transfusion.

Dorman SE, Cannon ME, Telford SR 3rd, Frank KM, Churchill WH.

Transfusion. 2000 Mar;40(3):375-80.

PMID:
10738042
6.

Plateletpheresis efficiency: a comparison of the spectra LRS and AMICUS separators.

Benjamin RJ, Rojas P, Christmas S, Neal J, Broughton S, Burgio C, Barrett B, Churchill WH.

Transfusion. 1999 Aug;39(8):895-9.

PMID:
10504127
7.

The pathology of transfusion-related acute lung injury.

Dry SM, Bechard KM, Milford EL, Churchill WH, Benjamin RJ.

Am J Clin Pathol. 1999 Aug;112(2):216-21.

8.

ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation.

Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH.

Transfusion. 1999 Feb;39(2):179-87.

PMID:
10037129
9.

Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.

Benjamin RJ, Connors JM, McGurk S, Churchill WH, Antin JH.

Biol Blood Marrow Transplant. 1998;4(3):151-6.

10.

Perceptions and preferences of autologous blood donors.

Lee SJ, Liljas B, Churchill WH, Popovsky MA, Stowell CP, Cannon ME, Johannesson M.

Transfusion. 1998 Aug;38(8):757-63.

PMID:
9709784
11.

Collection and transfusion of blood and blood components in the United States, 1994.

Wallace EL, Churchill WH, Surgenor DM, Cho GS, McGurk S.

Transfusion. 1998 Jul;38(7):625-36.

PMID:
9683100
12.

The Collaborative Hospital Transfusion Study: variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery.

Churchill WH, McGurk S, Chapman RH, Wallace EL, Bertholf MF, Goodnough LT, Kao KJ, Olson JD, Woodson RD, Surgenor DM.

Transfusion. 1998 Jun;38(6):530-9.

PMID:
9661686
13.

The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals.

Surgenor DM, Churchill WH, Wallace EL, Rizzo RJ, McGurk S, Goodnough LT, Kao KJ, Koerner TA, Olson JD, Woodson RD.

Transfusion. 1998 Feb;38(2):122-34.

PMID:
9531943
14.

Variations in transfusion practice in neonatal intensive care.

Ringer SA, Richardson DK, Sacher RA, Keszler M, Churchill WH.

Pediatrics. 1998 Feb;101(2):194-200.

PMID:
9445491
15.

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Wheeler C, Eickhoff C, Elias A, Ibrahim J, Ayash L, McCauley M, Mauch P, Schwartz G, Eder JP, Mazanet R, Ferrara J, Rimm IJ, Guinan E, Bierer B, Gilliland G, Churchill WH, Ault K, Parsons S, Antman K, Schnipper L, Tepler I, Gaynes L, Frei E 3rd, Kadin M, Antin J.

Biol Blood Marrow Transplant. 1997 Jun;3(2):98-106.

PMID:
9267670
16.

Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components.

Fountain D, Ralston M, Higgins N, Gorlin JB, Uhl L, Wheeler C, Antin JH, Churchill WH, Benjamin RJ.

Transfusion. 1997 Jun;37(6):585-91.

PMID:
9191818
17.

Patients' willingness to pay for autologous blood donation.

Lee SJ, Neumann PJ, Churchill WH, Cannon ME, Weinstein MC, Johannesson M.

Health Policy. 1997 Apr;40(1):1-12.

PMID:
10165898
18.

Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation--treatment with anti-D immunoglobulin.

Lee SJ, Churchill WH, Konugres A, Gilliland DG, Antin JH.

Bone Marrow Transplant. 1997 Jan;19(2):173-4.

19.

Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield.

Benjamin RJ, Linsley L, Fountain D, Churchill WH, Sieff C, Cannon ME, Uhl L, Gaynes L, Antin JH, Wheeler C.

Transfusion. 1997 Jan;37(1):79-85.

PMID:
9024494
20.

Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study.

Surgenor DM, Churchill WH, Wallace EL, Rizzo RJ, Chapman RH, McGurk S, Bertholf MF, Goodnough LT, Kao KJ, Koerner TA, Olson JD, Woodson RD.

Transfusion. 1996 Jun;36(6):521-32.

PMID:
8669084
Items per page

Supplemental Content

Loading ...
Write to the Help Desk